Recent News for MNTA - Momenta Pharmaceuticals, Inc.

Date Title
Aug 8 Momenta Continues Its Transition
Aug 8 Momenta Pharma files for mixed shelf
Aug 6 Edited Transcript of MNTA earnings conference call or presentation 2-Aug-19 12:30pm GMT
Aug 5 Momenta Pharmaceuticals Inc (MNTA) Q2 2019 Earnings Call Transcript
Aug 5 Momenta (MNTA) Q2 Loss Wider Than Expected, Revenues Miss
Aug 2 Momenta Pharmaceuticals, Inc. 2019 Q2 - Results - Earnings Call Slides
Aug 2 Momenta Pharmaceuticals, Inc. (MNTA) CEO Craig Wheeler on Q2 2019 Results - Earnings Call Transcript
Aug 2 Momenta misses Q3 consensus
Aug 2 Momenta Pharmaceuticals (MNTA) Reports Q2 Loss, Misses Revenue Estimates
Aug 2 Momenta Pharmaceuticals EPS misses by $0.73, misses on revenue
Aug 2 Momenta Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results
Aug 1 Momenta Pharmaceuticals Q2 Earnings Preview
Aug 1 Momenta Pharmaceuticals Launches Phase 2/3 Trial of M281 for the Treatment of Warm Autoimmune Hemolytic Anemia and is Granted FDA Fast Track Designation
Jul 30 Momenta's M281 Fast Track'd for newborn blood disorder; shares up 3% premarket
Jul 30 Momenta Pharmaceuticals Announces Fast Track Designation for M281 (nipocalimab) in Hemolytic Disease of the Fetus and Newborn (HDFN)
Jul 29 40 Healthcare Stocks Moving In Friday's After-Market Session
Jul 27 The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Jul 19 Momenta Pharmaceuticals Announces Date of Second Quarter 2019 Financial Results Conference Call and Webcast
Jun 19 Momenta Pharmaceuticals Announces Settlement Agreement with Amphastar Resolving Enoxaparin Sodium Injection Litigation
Jun 19 Amphastar settles litigation with Momenta and Sandoz
Jun 17 Did You Manage To Avoid Momenta Pharmaceuticals's (NASDAQ:MNTA) 47% Share Price Drop?
Jun 4 Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 40th Annual Global Healthcare Conference
Jun 1 Momenta (MNTA) Down 16.6% Since Last Earnings Report: Can It Rebound?
May 9 Momenta Pharmaceuticals to Webcast Presentation at the 2019 Bank of America Merrill Lynch Healthcare Conference
May 7 Momenta Pharmaceuticals Wants to Be the "Humira of the FcRn Space"
Back to the Main MNTA Page...